Physician profile
Danielle Keller
NPI 1366098436
$2,344.07
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.96 · 2022: $134 · 2023: $1,430 · 2024: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,111 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,110.54 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $748.42 | 2022-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.38 | 2023-2024 | Ofev, Jardiance |
| Harmony Biosciences LLC | $181.09 | 2023-2024 | Wakix |
| Novo Nordisk INC | $142.22 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $136.34 | 2023-2024 | |
| United Therapeutics Corporation | $132.67 | 2023-2024 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $125.68 | 2023-2024 | Airsupra, Breztri, Farxiga |
| Electromed, INC. | $118.70 | 2023-2024 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $113.06 | 2023-2024 | |
| Aerin Medical INC. | $111.03 | 2021-2023 | |
| Mylan Specialty L.P. | $104.53 | 2023-2024 | Yupelri |
| Abbvie INC. | $62.42 | 2023 | |
| Shield Therapeutics INC | $51.89 | 2023-2024 | Accrufer |
| Baxter Healthcare | $35.65 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Stryker Corporation | $18.57 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $17.88 | 2024 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.22 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $14.33 | 2024 | Winrevair |
| Optinose US, INC. | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.